Donut Hole Drug Prices Kept In Check By ACA, Report Says

Law360, New York (October 30, 2012, 5:22 PM EDT) -- Brand-name drug prices increased at a higher rate than normal in the first year of the Affordable Care Act's Medicare Part D discount program, but did not rise any faster for beneficiaries in the “donut hole” than for other beneficiaries, according to a U.S. Government Accountability Office report Friday.

Among its myriad provisions, the ACA attempts to close the Medicare Part D coverage gap, known as the donut hole, between initial and catastrophic coverage for drugs. Before 2011, beneficiaries paid 100 percent of drug costs when...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.